1.Propofol Inhibits Platelet-derived Growth Factor-stimulated Migration in Rat Aortic Smooth Muscle Cells.
Kyuchang LEE ; Keunsang LEE ; Bokyung KIM ; Jeongae LIM ; Jaiwon KOO ; Myeongjong LEE ; Hwan Myung LEE ; Chang Kwon LEE ; Kyung Jong WON
Korean Journal of Anesthesiology 2008;54(3):S22-S28
BACKGROUND: Propofol is the extensively used general anesthetic-sedative agent.Although propofol is known to be involved in migration of various cells, migration response to it in vascular smooth muscle cells is not investigated. This study was carried out to determine the role of propofol in migration of rat aortic smooth muscle cells (RASMCs). METHODS: A7r5 RASMCs were used.Cell migration was examined by the analysis of 5 ng/ml of platelet-derived growth factor (PDGF)-induced RASMC response after treatment of cells with propofol (1-100micrometer) in the Boyden chamber.The activity of cofilin by propofol in RASMCs was measured by the Western blot analysis for the change of cofilin dephosphorylaton in cells treated with 10micrometer propofol for 5, 10, 15 and 20 min, for the effect of propofol (1, 10 and 100micrometer) on cofilin phosphorylation, and for the effects of ethylene glycol-bis (beta-aminoethyl ether)-N,N,N',N'-tetra acetic acid (2 mM; EGTA), Na3VO4 (200micrometer), and calyculin A (10 nM) on 10micrometer propofol-induced cofilin dephosphorylation. RESULTS: PDGF increased RASMC migration and this response was dose-dependently inhibited by treatment with propofol. Propofol attenuated the cofilin phosphorylation in RASMCs in a dose- and time-dependent manner.Propofol-induced dephosphorylation of cofilin in RASMCs was abolished by calyculin A, a protein phosphatase 2A inhibitor, but not by EGTA, a Ca2+ chelating agent, or Na3VO4, a protein tyrosine phosphatase inhibitor. CONCLUSIONS: The present results suggest that propofol induces the diminution of PDGF-stimulated RASMC migration and this response may be associated with dephosphorylation of cofilin mediated by the protein phosphatase 2A-dependent pathway.
Acetic Acid
;
Animals
;
Blotting, Western
;
Egtazic Acid
;
Emigration and Immigration
;
Ethylenes
;
Muscle, Smooth
;
Muscle, Smooth, Vascular
;
Myocytes, Smooth Muscle
;
Oxazoles
;
Phosphorylation
;
Platelet-Derived Growth Factor
;
Propofol
;
Protein Phosphatase 2
;
Protein Tyrosine Phosphatases
;
Rats
2.Clinical Practice Guideline for the Diagnosis and Treatment of Pediatric Obesity: Recommendations from the Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology Hepatology and Nutrition.
Dae Yong YI ; Soon Chul KIM ; Ji Hyuk LEE ; Eun Hye LEE ; Jae Young KIM ; Yong Joo KIM ; Ki Soo KANG ; Jeana HONG ; Jung Ok SHIM ; Yoon LEE ; Ben KANG ; Yeoun Joo LEE ; Mi Jin KIM ; Jin Soo MOON ; Hong KOH ; JeongAe YOU ; Young Sook KWAK ; Hyunjung LIM ; Hye Ran YANG
Pediatric Gastroenterology, Hepatology & Nutrition 2019;22(1):1-27
The Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition newly developed the first Korean Guideline on the Diagnosis and Treatment of Obesity in Children and Adolescents to deliver an evidence-based systematic approach to childhood obesity in South Korea. The following areas were systematically reviewed, especially on the basis of all available references published in South Korea and worldwide, and new guidelines were established in each area with the strength of recommendations based on the levels of evidence: 1) definition and diagnosis of overweight and obesity in children and adolescents; 2) principles of treatment of pediatric obesity; 3) behavioral interventions for children and adolescents with obesity, including diet, exercise, lifestyle, and mental health; 4) pharmacotherapy; and 5) bariatric surgery.
Adolescent
;
Bariatric Surgery
;
Child
;
Diagnosis*
;
Diet
;
Drug Therapy
;
Gastroenterology*
;
Humans
;
Korea
;
Life Style
;
Mental Health
;
Obesity
;
Overweight
;
Pediatric Obesity*
3.Clinical practice guideline for the diagnosis and treatment of pediatric obesity: recommendations from the Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology Hepatology and Nutrition.
Dae Yong YI ; Soon Chul KIM ; Ji Hyuk LEE ; Eun Hye LEE ; Jae Young KIM ; Yong Joo KIM ; Ki Soo KANG ; Jeana HONG ; Jung Ok SHIM ; Yoon LEE ; Ben KANG ; Yeoun Joo LEE ; Mi Jin KIM ; Jin Soo MOON ; Hong KOH ; JeongAe YOU ; Young Sook KWAK ; Hyunjung LIM ; Hye Ran YANG
Korean Journal of Pediatrics 2019;62(1):3-21
The Committee on Pediatric Obesity of the Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition newly developed the first Korean Guideline on the Diagnosis and Treatment of Obesity in Children and Adolescents to deliver an evidence-based systematic approach to childhood obesity in South Korea. The following areas were systematically reviewed, especially on the basis of all available references published in South Korea and worldwide, and new guidelines were established in each area with the strength of recommendations based on the levels of evidence: (1) definition and diagnosis of overweight and obesity in children and adolescents; (2) principles of treatment of pediatric obesity; (3) behavioral interventions for children and adolescents with obesity, including diet, exercise, lifestyle, and mental health; (4) pharmacotherapy; and (5) bariatric surgery.
Adolescent
;
Bariatric Surgery
;
Child
;
Diagnosis*
;
Diet
;
Drug Therapy
;
Gastroenterology*
;
Humans
;
Korea
;
Life Style
;
Mental Health
;
Obesity
;
Overweight
;
Pediatric Obesity*